GW0742 + SR9011 Tablets
GW0742 + SR9011 is offered in 2 variants: 10mg GW0742 and 10mg SR9011, totaling 20mg per tablet for 27 tablets or 540mg in total: 10mg GW0742 and 10mg SR9011, totaling 20mg per tablet for 54 tablets or 1080mg in total.
GW-0742 is a PPARβ/δ agonist, which is being dubbed as a ‘Super Cardarine’. Studies have shown GW0742 has the ability to improve glucose homeostasis and increase insulin sensitivity in diabetic rats. In diabetic rats fed a high fructose diet, a group given GW0742 showed lower blood sugar compared to the control group. Due to GW0742 being a PPAR agonist it showed potential in increasing fat loss by boosting metabolism and stimulating the utilization of fat for fuel. This could potentially increase the oxidative capacity of muscles helping burn more calories.
|IUPAC Name||2-[4-[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methylsulfanyl]-2-methylphenoxy]acetic acid|
A recent study on diet-induced obese mice treated with SR9009 and SR9011 (i.e., two times a day for 30 days) have been reported to display decreased fat mass and markedly improved dyslipidemia and hyperglycemia. The activation of REV-ERB leads to the enhancement of circadian rhythm observed in mice. This affects behaviour, sleep cycle and some functions related to increment in energy production.
|Molar Mass||479.04 g·mol−1|
By completing and paying for your order, you agree to our Terms and Conditions. Customer satisfaction is our number one priority, if you are not 100% satisfied with the product you received, please contact us at email@example.com
We are not affiliated, associated, authorized, endorsed by, or in any way officially connected with SARMScentral.org, or any of its subsidiaries or its affiliates.